Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 9, Number 12—December 2003

Research

Trypanosoma cruzi in Persons without Serologic Evidence of Disease, Argentina

Oscar A. Salomone*Comments to Author , Ana L. Basquiera*, Adela Sembaj†, Ana M. Aguerri†, María E. Reyes‡, Mirtha Omelianuk*, Ruth A. Fernández†, Julio Enders†, Atilio Palma†, José Moreno Barral†, and Roberto J. Madoery*
Author affiliations: *Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina; †Universidad Nacional de Córdoba, Córdoba, Argentina; ‡Ministerio de Salud de Córdoba, Córdoba, Argentina

Main Article

Figure

Gel electrophoresis analysis of a polymerase chain reaction (PCR) product corresponding to a highly repetitive 220-bp Trypanosoma cruzi nuclear fragment. 1: molecular weight standards, 2: T . cruzi nuclear 220-bp PCR product, 3 and 4: PCR product from patients blood, 5: PCR negative control (arrows correspond to 220 bp).

Figure. Gel electrophoresis analysis of a polymerase chain reaction (PCR) product corresponding to a highly repetitive 220-bp Trypanosoma cruzi nuclear fragment. 1: molecular weight standards, 2: T . cruzi nuclear 220-bp PCR product, 3 and 4: PCR product from patients blood, 5: PCR negative control (arrows correspond to 220 bp).

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO